SOTERA HEALTH COMPANY OCI, before Reclassifications, Net of Tax, Attributable to Parent
SOTERA HEALTH COMPANY (SHC) reported OCI, before Reclassifications, Net of Tax, Attributable to Parent of -$17.48 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Income Statement › Unrealized Gains
us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent · last filed 2026-08-06
- SOTERA HEALTH COMPANY oci, before reclassifications, net of tax, attributable to parent for the quarter ending 2026-06-30 was -$17.48M, a 121.47% decline year-over-year.
- SOTERA HEALTH COMPANY oci, before reclassifications, net of tax, attributable to parent for the quarter ending 2026-03-31 was -$16.04M, a 184.10% decline year-over-year.
- SOTERA HEALTH COMPANY oci, before reclassifications, net of tax, attributable to parent for the quarter ending 2025-12-31 was $15.97M.
- SOTERA HEALTH COMPANY oci, before reclassifications, net of tax, attributable to parent for the quarter ending 2025-09-30 was -$16.86M, a 174.02% decline year-over-year.
- SOTERA HEALTH COMPANY oci, before reclassifications, net of tax, attributable to parent for fiscal 2025 was $99.60M.
- SOTERA HEALTH COMPANY oci, before reclassifications, net of tax, attributable to parent for fiscal 2024 was -$105.55M, a 390.73% decline from fiscal 2023.
- SOTERA HEALTH COMPANY oci, before reclassifications, net of tax, attributable to parent for fiscal 2023 was $36.31M.
| Period end | OCI, before Reclassifications, Net of Tax, Attributable to Parent 3 month | OCI, before Reclassifications, Net of Tax, Attributable to Parent 6 month | OCI, before Reclassifications, Net of Tax, Attributable to Parent 9 month | OCI, before Reclassifications, Net of Tax, Attributable to Parent 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$17.48M 10-Q · filed 2026-08-06 | -$33.52M 10-Q · filed 2026-08-06 | -$17.55M derived: sum of 3 quarters · filed 2026-08-06 | -$34.41M derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | -$16.04M 10-Q · filed 2026-05-05 | -$68.00K derived: sum of 2 quarters · filed 2026-05-05 | -$16.93M derived: sum of 3 quarters · filed 2026-05-05 | $64.50M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | $15.97M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | -$896.00K derived: sum of 2 quarters · filed 2026-02-24 | $80.54M derived: sum of 3 quarters · filed 2026-08-06 | $99.60M 10-K · filed 2026-02-24 |
| 2025-09-30 | -$16.86M 10-Q · filed 2025-11-04 | $64.57M derived: sum of 2 quarters · filed 2026-08-06 | $83.64M 10-Q · filed 2025-11-04 | $677.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | $81.43M 10-Q · filed 2026-08-06 | $100.50M 10-Q · filed 2026-08-06 | $17.54M derived: sum of 3 quarters · filed 2026-08-06 | $40.32M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | $19.07M 10-Q · filed 2026-05-05 | -$63.89M derived: sum of 2 quarters · filed 2026-05-05 | -$41.11M derived: sum of 3 quarters · filed 2026-05-05 | -$62.98M derived: sum of 4 quarters · filed 2026-05-05 |
| 2024-12-31 | -$82.96M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | -$60.18M derived: sum of 2 quarters · filed 2026-02-24 | -$82.05M derived: sum of 3 quarters · filed 2026-02-24 | -$105.55M 10-K · filed 2026-02-24 |
| 2024-09-30 | $22.78M 10-Q · filed 2025-11-04 | $913.00K derived: sum of 2 quarters · filed 2025-11-04 | -$22.59M 10-Q · filed 2025-11-04 | |
| 2024-06-30 | -$21.87M 10-Q · filed 2025-08-08 | -$45.38M 10-Q · filed 2025-08-08 | ||
| 2023-12-31 | $36.31M 10-K · filed 2026-02-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Progyny, Inc. (PGNY) | United States | $1.994B | 28.37 |
| agilon health, inc. (AGL) | United States | $1.272B | -7.76 |
| VIEMED HEALTHCARE, INC. (VMD) | United States | $0.336B | 29.92 |
| Park Dental Partners, Inc. (PARK) | United States | $0.094B | |
| BioRestorative Therapies, Inc. (BRTX) | United States | $0.064B | |
| CRYO CELL INTERNATIONAL INC (CCEL) | United States | $0.033B | -11.02 |
| MANGOCEUTICALS, INC. (MGRX) | United States | $0.010B | -0.43 |
| DAVITA INC. (DVA) | United States | $11.147B | 16.80 |